Sources | Names Used |
---|---|
CTRPv2 | selumetinib:GDC-0941 (4:1 mol/mol) |
PharmacoGx | selumetinib:GDC-0941 (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SCNN1D | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
mRNA | OSBPL8 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
mRNA | EEF1E1-BLOC1S5 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
mRNA | NCAPD3 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
mRNA | S1PR2 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
mRNA | LYPLA2 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
mRNA | TCTEX1D2 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
mRNA | RP11-385J1.3 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | FCER1G | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
mRNA | IFRD1 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |